3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other solid neoplasm
1
Conditions
Carcinoma, Non-Small-Cell Lung
4
Uterine Cervical Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Retinoblastoma
1
Retinal Neoplasms
1
Oropharyngeal Neoplasms
1
Nonsquamous Non-small Cell Lung Cancer
1
Melanoma
1
Carcinoma, Squamous Cell
1
Carcinoma, Renal Cell
1
Interventions
Vincristine
3
Etoposide
3
Carboplatin
3
Cyclophosphamide
2
trioctyl phosphine oxide
1
pembrolizumab
1
pegfilgrastim
1
Topotecan
1
Thiotepa
1
Surveys and Questionnaires
1
Platinum Compounds
1
Observation
1
Mesna
1
Melphalan
1
Lasers, Semiconductor
1
Lasers
1
Granulocyte Colony-Stimulating Factor
1
Filgrastim
1
Eye Enucleation
1
Drug Therapy
1
Doxorubicin
1
Cytapheresis
1
Cryotherapy
1
Brachytherapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Active not recruiting
×
Retinoblastoma
×
Platinum Compounds
×
Clear all
NCT02866136
2025-11-24
RETINO2011
Institut Curie
Phase 2
Active not recruiting
133 enrolled